| HOME >> BIOLOGY >> TECHNOLOGY |
Before Income Taxes 881.3 209.4
Provision for Income Taxes (101.7) (43.1)
Income from Continuing Operations 779.6 166.3
Income from Discontinued Operations
(net of income tax
provision of $0.2 in 2006) - 0.5
(Loss) Gain on Disposal of
Discontinued Operations (Includes
income tax provision of $6.4 and
$1.1) (18.5) 2.1
Net Income $761.1 7.8% $168.9 4.5%
Earnings per Share from Continuing
Operations:
Basic $1.85 $.85
Diluted $1.76 $.82
Earnings per Share:
Basic $1.81 $.86
Diluted $1.72 $.84
Weighted Average Shares:
Basic 421.5 196.1
Diluted 443.7 203.7
Reconciliation of Adjusted Operating
Income and Adjusted Operating Margin
GAAP Operating Income (a) $974.4 10.0% $242.0 6.4%
Cost of Revenues Charges (c) 49.2 0.5% 77.7 2.0%
Restructuring and Other Costs,
Net (d) 42.2 0.4% 45.7 1.2%
Equity Compensation Acceleration
Charges (e) - 0.0% 36.7 1.0%
Amortization of Acquisition-related
Intangible Assets 571.1 5.9% 170.8 4.5%
Adjusted Operating Income (b) $1,636.9 16.8% $572.9 15.1%
Reconciliation of Adjusted Net Income
GAAP Net Income (a) $761.1 7.8% $168.9 4.5%
Cost of Revenues Charges (c)
'/>"/>
| SOURCE Thermo Fisher Scientific Inc. Copyright©2008 PR Newswire. All rights reserved |